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 ABSTRACT 
 Objective  To investigate if carriage of interleukin 1 (IL-
1) receptor antagonist gene variants are associated with 
sudden infant death syndrome (SIDS) in a large cohort of 
case–control demographically matched infants. 
 Design  118 SIDS and 233  control infants, who were 
matched to each SIDS infant by date of birth, sex, birth 
weight (±500 g), gestational age and ethnicity, were 
genotyped for an  IL-1RN 89 bp tandem repeat polymor-
phism and analysed for signifi cant associations. 
 Results  No signifi cant difference in genotype frequen-
cies was observed between low and normal birthweight 
infants and year of birth (1987–1994, when the SIDS 
incidence was higher). In infants born between 1987 and 
1994, an association was observed with SIDS and allele 
2 where 18% of SIDS infants carried the 2/2 genotype 
compared with 9% of controls (χ 2 p=0.026, OR 2.46). 
Allele 3 was found at a low frequency, but was signifi -
cantly more common in SIDS infants (3.1%) compared 
with controls (0.9%, Fisher’s exact p=0.04, OR 3.76). 
 Conclusion  The higher prevalence of  IL-1RN allele 2, 
which predisposes to poor outcomes from infection, 
in SIDS infants born between 1987 and 1994 (ie, prior 
to the dramatic decrease in SIDS incidence) suggests 
that the high incidence during this period could point to 
infection playing a role in aetiology. An association of 
 IL-1RN allele 3 with SIDS was also found, but should be 
interpreted with caution due to the low frequency of this 
variant. The consequence of allele 3 carriage is currently 
unknown in the absence of functionality studies for this 
isoform. 
 INTRODUCTION 
 The mainstream perspective of sudden infant 
death syndrome (SIDS) is that of a multi-factorial 
disorder inﬂ uenced by developmental, environ-
mental and biological risk factors.  1  The envi-
ronmental risk factors for SIDS parallel those 
for serious infections  2  and a signiﬁ cant number 
of SIDS cases present with symptoms of infec-
tious diseases shortly before death.  3  Infections 
are very common in the ﬁ rst year of life, more 
so than the incidence of SIDS;  4  thus, if infec-
tion plays a role in the cause of SIDS, a biologi-
cal risk or predisposing factor might be involved. 
The hypothesis that SIDS pathogenesis may be 
via an inappropriate immune response to infec-
tion has prompted numerous cytokine gene 
polymorphism association studies  5  –  9  including 
an investigation into interleukin 1β C-511T and 
interleukin 1 (IL-1) receptor antagonist ( IL-1RN  ) 
T+2018C single nucleotide polymorphisms.  10  IL-1 
is a cytokine responsible for causing rapid vaso-
dilation in septic shock which can be induced by 
 Staphylococcus aureus toxins  11  which are suspected 
to play a role in SIDS.  12    13  In previously published 
work we conducted a pilot study investigating 
the  IL-1RN 89 bp variable number of tandem 
repeats (VNTR) polymorphism genotype, in 
cases of unexplained sudden unexpected death 
in infancy (uSUDI). This group consisted of SIDS 
infants from South Australia matching the 1989 
deﬁ nition for SIDS  14  and 10 infants from Victoria 
constituting one category 1a and seven category 
2 SIDS infants meeting the 2004 deﬁ nitions for 
SIDS  15  and two unascertained cases  16  An asso-
ciation was found between the homozygous 2 
allele (A2) and uSUDI (p=0.007) where carriage 
of the 2/2 genotype gave a 4.85 times increased 
risk of uSUDI compared with the predominant 
1/1 genotype. Unfortunately, gestational age 
data were not available for this cohort and as 
preterm birth is a risk factor for SIDS it could be 
over-represented in the uSUDI cohort compared 
with the control group. The live infant control 
group had an excess of males (62%) compared 
with the uSUDI group (54%) and was collected 
prospectively during a different decade from the 
majority of the uSUDI cases, during which geno-
types could be inﬂ uenced by different selective 
 1 Department of Microbiology 
and Infectious Diseases, SA 
Pathology at the Women’s 
& Children’s Hospital, North 
Adelaide, South Australia, 
Australia 
 2 Discipline of Paediatrics, 
School of Paediatrics 
and Reproductive Health, 
University of Adelaide, North 
Adelaide, South Australia, 
Australia 
 3 Discipline of Obstetrics 
and Gynaecology, School of 
Paediatrics and Reproductive 
Health, University of Adelaide, 
North Adelaide, South 
Australia, Australia 
 Correspondence to 
Amanda R Highet, University 
of Adelaide, Department of 
Obstetrics and Gynaecology, 
Level 6 Medical School North, 
Frome Road, Adelaide 5005, 
South Australia, Australia; 
amanda.highet@adelaide.
edu.au 
 Variant interleukin 1 receptor antagonist gene alleles 
in sudden infant death syndrome 
 Amanda R  Highet, 1,2  Catherine S  Gibson, 3  Paul N  Goldwater 1,2 
 What is already known on this topic 
 Polymorphic genotypes conferring more  ▶
severe pro-infl ammatory responses are 
found more frequently in sudden infant death 
 syndrome (SIDS) infants than controls. 
 Carriage of the 2/2   ▶ IL-1RN genotype increases 
the risk of unexplained sudden unexpected 
death in infancy 4.85 times compared with the 
 predominant 1/1 genotype 
 What this study adds 
 The role of infection in SIDS could be via an  ▶
immune response pathway where the  IL-1RN 
genotype plays a critical role 
 The increased prevalence of   ▶ IL-1RN A2 in SIDS 
infants born before 1995 could point to an 
infection playing a role in the aetiology. 
 An association of the   ▶ IL-1RN allele 3 with 
SIDS was observed. The signifi cance of this is 
 limited by its low frequency and the absence of 
functionality studies for this variant. 
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pressures. The possible association between  IL-1RN A2 and 
uSUDI needed to be investigated further in a larger cohort 
with greater statistical power and ideally matched (for date 
of birth, sex and birth weight) controls. This study was 
designed to investigate whether the carriage of 2/2 genotype 
is associated with SIDS when cases are matched to controls 
for preterm birth and gender, and to analyse for potential 
new associations in a larger cohort. 
 MATERIALS AND METHODS 
 Selection criteria 
 The South Australian Neonatal Screening Laboratory assisted 
us in identifying the newborn screening cards (NSCs) of 120 
conﬁ rmed SIDS cases and 240 matched healthy infant con-
trols. All SIDS infants met the criteria speciﬁ c to the deﬁ ni-
tion for SIDS at their time of death (either the 1969,  17  1989  14  
or 2004  15  deﬁ nition) and have been recorded as such in the 
register of infant deaths held by the Pregnancy Outcomes 
Statistics Unit of the South Australian Department of Health. 
Two control infants were matched to each SIDS infant by 
date of birth, sex, birth weight (±500 g), gestational age, time 
lapsed from birth to NSC sampling and ethnicity. Time lapsed 
from birth to NSC sampling was matched for future investi-
gations where age at the time of sampling might be a con-
founding factor. They were checked against the pregnancy 
outcomes database to ensure they were suitably matched, did 
not have any birth defects notiﬁ ed and had survived at least 
the neonatal period (the ﬁ rst 28 days). The NSCs of 118 SIDS 
and 233  control infants were located and sampled (changes 
over time in the accession and storage of NSCs rendered 
some of the older samples inaccessible). Eighty-four per cent 
of NSCs (SIDS cases and controls) were from infants born 
between 1987 and 1994 and 16% born between 1995 and 
2006. Twenty-nine SIDS infants were included in both the 
previous pilot study  16  and the present cohort (ie, their NSCs 
could be identiﬁ ed and located). Birth weight and gestational 
age are closely correlated; birth weight was chosen for suba-
nalysis because data were available for all infants (six con-
trols had no gestational age recorded). 
 Sample preparation 
 A single 1.2 mm diameter punch biopsy was taken from each 
dried blood sample with 20 punches of blank card in between 
to prevent carry-over contamination. Nucleic acids were 
released from the punches by treating with a cell lysis and 
solution containing 50% w/v Chelex-100 (Biorad, Hercules, 
California, USA), 2% w/v SDS, 0.1 M Tris and 5 mM EDTA . 
Chelex-100 binds to polar cellular components from the lysed 
cells leaving the nucleic acids free in the supernatant solution. 
Then 1 mg of proteinase K was added, and the solution was 
incubated at 60°C for 30 min to digest cellular proteins (Roche, 
Mannheim, Germany) and then heated to 95°C for 30 min to 
denature the DNA. Chelex-100 was pelleted by centrifugation, 
the supernatant was diluted 10-fold and 2 μl was used in each 
PCR. 
 PCR amplifi cation 
 IL-1RN was ampliﬁ ed using the primer pair published by 
Tarlow  et al  18  with the following cycling conditions: 95°C 
2 min, 38 cycles of 95°C 30 s, 59°C 30 s, 72°C 1 min and a 
ﬁ nal extension of 72°C 3 min on a Bio-Rad IQ5 cycler (Biorad). 
 IL-1RN genotype was determined by the amplicon size (VNTR) 
as described by Tarlow  et al  18  The amplicon sizes were: allele 1 
(A1) 410 bp; A2 240 bp; A3 500 bp; A4 325 bp and A5 595 bp. 
Each PCR consisted of 0.05 μM MgCl 2 , 1× Colourless GoTaq 
Flexi Buffer, 0.025 μM dNTP mix, 0.05 μM each of the primer 
pair and 0.5 units GoTaq DNA Polymerase (Promega, Madison 
Wisconsin, USA), 2 μl of extracted DNA and PCR-grade water 
to a total volume of 12.5 μl. Ampliﬁ cation products were 
visualised on a 2% agarose gel stained with GelRed (BioTium, 
Hayward, California, USA) alongside a pUC19/ Hpa II DNA 
molecular weight marker (Geneworks, Thebarton, South 
Australia). Homozygous 1/1 and 2/2 controls for each geno-
type were sourced from the study cohort and conﬁ rmed by 
sequencing the ampliﬁ cation products (IMVS Sequencing 
Centre, Adelaide, South Australia). 
 Statistics 
 The statistical power for a study with 118 cases and 233 con-
trol subjects, when prior data indicate that the probability of 
A2 among controls is 0.2 based upon the allele frequencies for 
cases and controls observed in the pilot study,  16  was calculated 
using PS Power and Sample Size Calculations (V.3.0, January 
2009). If the true probability of A2 exposure among cases is 
0.37, we will be able to reject the null hypothesis that the expo-
sure rates for cases and controls are equal with a probability 
(power) of 92.2%. The type I error probability associated with 
this test of the null hypothesis is 0.05. Yates corrected proba-
bility test using the 2 × 2 contingency table software (Statcalc, 
Epiinfo V.6) was applied to evaluate this null hypothesis. SIDS 
genotypes were analysed against those of live control infants 
by comparing homozygous and heterozygous variant allele 
carriage with the 1/1 genotype using χ 2 and Fisher’s exact tests 
where appropriate. To compare the controlled variables for the 
SIDS and control groups, χ 2 was used to test for signiﬁ cant dif-
ferences in categorical variables (ethnicity, gender and month 
of birth) and Mann–Whitney U test for continuous variables 
not expected to follow a normal distribution (gestational age 
and birth weight). 
 Ethical considerations 
 Approval was granted by the Human Research Ethics 
Committee of the Children Youth Women’s Health Service, 
North Adelaide, to test NSCs from SIDS and control infants 
using samples which were ‘re-identiﬁ able’, marked with only 
a laboratory number linked to data held by an external party 
(The South Australian Pregnancy Outcomes Statistics Unit). 
The investigators were blind to the identities of the infants, 
and their SIDS/control status for the duration of this study. 
 RESULTS 
 IL-1RN genotypes in SIDS and control infants 
 IL-1RN VNTR genotype and allele frequencies for SIDS and 
control infants are shown in  tables 2 and  3 , respectively. Not all 
samples gave a valid result due to the presence of PCR inhibi-
tors in blood, or possible DNA degradation after prolonged NSC 
storage.  Table 1 shows the distribution of controlled variables 
for the successfully genotyped SIDS and control cohorts. One 
hundred and thirteen SIDS infants and 218 controls gave a valid 
 IL-1RN genotype result ( table 2 ). The statistical power of the 
study to detect the expected difference in A2 carriage based on 
previous data  16  was still valid (power=90.9%). Heterozygous 
1/2 and homozygous 2/2 genotypes were analysed against 
the 1/1 genotype for SIDS compared with control infants. No 
association was shown between A2 and SIDS. Comparison of 
genotype and allele frequencies between males and females, 
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low birthweight (≤2500 g) and normal birthweight (>2500 g) 
infants revealed that the 1/2 genotype was more common in 
SIDS and control combined males (47 out of 190, 24.7%) com-
pared with females (21 out of 141, 14.9%) (p=0.039, OR=1.91, 
95% CI 1.04 to 3.60), while there was no genotype frequency 
differences between the birthweight categories. A3 carriage 
was signiﬁ cantly more common in SIDS (3.1%) compared 
with control infants (0.9%, p=0.04, OR=3.76, 95% CI 0.94 to 
17.74;  table 3 ). 
 IL-1RN genotypes in SIDS and control infants born 1987–1994 
 Genotypes of 94 SIDS infants (29 were also in the pilot study) 
and 185 controls born in the period 1987–1994 were compared 
separately for associations as these infants died when SIDS 
displayed a particularly high incidence. Of the SIDS infants 
18.1% carried the 2/2 genotype compared with only 9.1% of 
the control infants ( table 2 ). Compared against carriage of the 
wild-type, this difference was signiﬁ cant (p=0.025, OR=2.48, 
95% CI 1.09 to 5.59). 
 DISCUSSION 
 IL-1RN genotypes in SIDS and control infants 
 The aim of this study was to investigate if carriage of 2/2 
 IL-1RN genotype is associated with SIDS when compared 
with controls that have been matched for preterm birth and 
gender. On comparing the 2/2 and 1/1 genotype frequencies 
of 113 SIDS infants and 218 controls we found no signiﬁ cant 
differences. This was surprising given the results of our pre-
vious study of a smaller cohort, in which the 2/2 genotype 
was signiﬁ cantly associated with unexplained infant deaths 
which were predominantly SIDS.  16  The 1/2 genotype was 
signiﬁ cantly more frequent in males compared with females. 
This was an unexpected ﬁ nding which might be signiﬁ cant in 
relation to the increased risk of SIDS seen in males. However, 
since we saw no increase in the 2/2 ‘risk’ genotype in males, 
it is difﬁ cult to explain why the heterozygous combination 
(which should have intermediate IL-1ra expression) is more 
common. No signiﬁ cant difference in genotype frequencies 
was observed between low birthweight (≤2500 g) and normal 
birthweight (>2500 g) infants. A3 carriage was found to be sig-
niﬁ cantly more common in SIDS infants compared with con-
trol infants (p=0.04). However, as the frequency of this allele 
is relatively less common, the small numbers observed must be 
analysed with caution. This association could have gone unde-
tected in the smaller cohort examined in the pilot study due to 
the low statistical power. The biological effects of  IL1-RN A3, 
and whether it alters IL-1β production is currently unknown, 
but it has been implicated in recurrent spontaneous abortion, 
a condition believed to be promoted by a pro-inﬂ ammatory 
state.  19  The  IL-1RN A3 variant has been reported to lack an 
in-frame coding segment, as compared to variant 2, and the 
resulting isoform lacks an internal region ( NCBI Reference 
Sequence: NM_000577.3 data). Theoretically, this ‘less-func-
tional’ form of IL-1ra could be less efﬁ cient in binding IL-1 
receptors and might not exert immune control to the extent 
of the wild-type. Thus the association of A3 with SIDS might 
reﬂ ect unchecked IL-1β levels and subsequent progression to a 
severe pro- inﬂ ammatory response and possible death. 
 IL-1RN genotypes in SIDS and control infants born 1987–1994 
 In a previous pilot study we observed a signiﬁ cant associa-
tion between  IL-1RN A2 and uSUDI cases, which were pre-
dominantly SIDS infants who died in the early 1990s.  16  On 
examination of infants born in the period 1987–1994 in the 
present cohort, we found a signiﬁ cant association between 
SIDS and A2. These results suggest that the higher frequency 
of A2 observed in the pilot study could possibly be involved in 
SIDS from this time. However, as the number of cases decrease 
in subanalyses these results should be interpreted with cau-
tion to avoid type I error. 
 In the current study (including all birth years) we found 
the 1/2 genotype was signiﬁ cantly more common in males 
compared with females. This gender-speciﬁ c difference was 
unlikely to have accounted for the higher frequency of A2 in 
the SIDS/uSUDI group in the pilot study as the live control 
group had more males than the uSUDI group (54% vs 62%) 
and so theoretically should have over-represented A2. 
 There might be an epidemiological factor that could help 
explain why SIDS in the higher incidence period 1987–1994 
had a different  IL-1RN genotype distribution compared with 
latter cases. The SIDS rate in South Australia rose through 
the 1970s and early 1980s to a peak incidence of 2.4 per 
1000 live births in 1986, and then began to decrease.  20  This 
parallels the wave-like pattern of incidence typical of an 
 Table 2  Distribution of  IL-1RN genotypes among SIDS and control 
infants (n, (%)) 
 Genotype  SIDS (%)  Control (%) 
 SIDS born 
1987–1994 (%) 
 Controls born 
1987–1994 (%) 
1/1  67 (59.3) 148 (67.9) 52 (55.3) 128 (69.6)
1/2  23 (20.3)  45 (20.6) 21 (22.3)  35 (19.1)
2/2  18 (15.9)  21 (9.6) 17 (18.1)*  17 (9.3)
1/3   2 (1.8)   1 (0.5)  2 (2.1)   1 (0.5)
2/3   1 (0.9)   1 (0.5)  1 (1.1)   1 (0.5)
3/3   2 (1.8)   1 (0.5)  1 (1.1)   1 (0.5)
4/4   0   1 (0.5)  0   1 (0.5)
Total 113 (100) 218 (100) 94 (100) 184 (100)
 *p=0.026, OR 2.46 (1.08 to 5.55). 
 SIDS, sudden infant death syndrome. 
 Table 3  Distribution of  IL-1RN alleles among SIDS and control infants 
(n, (%)) 
 Allele  SIDS  Control 
 SIDS born 
1987–1994 
 Controls born 
1987–1994 
A1 159 (70.4%) 342 (78.5%) 127 (67.5%) 292 (79.3%)
A2  60 (26.5%) 88 (20.2%)  56 (29.8%)*  70 (19%)
A3   7 (3.1%)** 4 (0.9%)   5 (2.7%)   4 (1.1%)
A4   0 2 (0.4%)   0   2 (0.6%)
Total 226 (100%) 436 (100%) 188 (100%) 368 (100%)
 *p=0.004, OR 1.84 (1.19 to 2.82). 
 **p=0.04, OR 3.76 (0.94 to 17.74) (2-tailed Fisher’s exact). 
 SIDS, sudden infant death syndrome. 
 Table 1  Controlled variables for the SIDS and control cohorts 
  SIDS (n=113)  Control (n=218)  Signifi cance 
Caucasian 108 (95.6%) 198 (93.4%)* χ 2 p=0.476



















Month of birth  χ 2 p=1.0
 *Race and gestational age data available for 212 of the 218 control infants. 
 SIDS, sudden infant death syndrome. 
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infectious disease.  21    22  We propose that a major contribut-
ing factor to these deaths was infection, causing a high mor-
tality in infants whose risk was potentiated by an  IL-1RN 
2/2 genotype and were more susceptible to a sustained pro-
 inﬂ ammatory response. The decrease in babies being put to 
sleep in the prone position is a well-recognised preventive 
measure, which in some regions led to a decrease in SIDS 
deaths in the prone position.  23  Prone sleeping has been 
shown to promote the accumulation of staphylococci in the 
nasopharynx, a common ﬁ nding in SIDS.  24    25  IL-1 is induced 
by  S. aureus and the 2/2  IL-1RN genotype could predispose 
to a lethal response to the bacterium. However, data from 
South Australian SIDS cases between 1974 and 1997 indi-
cate that the percentage of cases found sleeping prone did 
not vary in this population, and as the majority of infants 
were still found prone  20  this does not suggest that the differ-
ences observed over time in this cohort were inﬂ uenced by a 
change in the sleeping position. 
 IL-1RN genotype-association studies in the published literature 
 A study of the same  IL-1RN VNTR polymorphism was 
recently published by Ferrante  et al  26  reporting no associa-
tion between any  IL-1RN VNTR genotype and SIDS infants 
who died in Norway. The infants studied were from the 
same period (1987/88 to 2006) and exhibited almost the same 
percentages of A2 homozygous SIDS and control infants as 
the present study, 15% SIDS with 2/2 in Ferrante’s study 
versus 15.9% in the present study, and 7% controls with 
2/2 in Ferrante’s study versus 9.6% in the present study. In 
Norway SIDS exhibited a similar decline in incidence to that 
in Australia, which began in the early 1990s. Accordingly if 
Ferrante  et al had analysed their cases born until 1995 sepa-
rately, a similar association with A2 might have been found. 
In a study by Moscovis  et al a single nucleotide polymor-
phism in  IL-1RN (T+2018C) was found not to be differently 
distributed between SIDS infants and  controls  10  , where the 
SIDS infants died between 1995 and 1997.  13  Similarly, if 
this experiment was replicated in our cohort of earlier SIDS 
infants, born prior to 1995, a higher frequency of  IL-1RN 
(T+2018C) might be observed, in parallel with our ﬁ ndings 
of higher  IL-1RN VNTR A2 in these infants. Such a ﬁ nding 
would support the involvement of  IL-1RN in SIDS. 
 CONCLUSION 
 The human immune system is extremely complex in nature 
and is controlled by a vast array of genes. While the list of 
candidate genes for polymorphism analysis in SIDS appears 
endless, those genes involved in immunoregulatory processes 
deserve special attention as they have a powerful affect on 
the homeostatic balance. The higher prevalence of  IL-1RN 
A2, which predisposes to poor outcomes from infection, in 
earlier SIDS cases suggests that the high incidence during 
this period could point to an underlying infectious aetiol-
ogy. An association of the  IL-1RN low frequency A3 with 
SIDS was also observed; however, the signiﬁ cance of this 
is unknown in the absence of functionality studies for this 
variant isoform. 
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